CSPC Innovation (China) Performance
| 300765 Stock | 28.51 0.27 0.94% |
On a scale of 0 to 100, CSPC Innovation holds a performance score of 7. The firm shows a Beta (market volatility) of 0.48, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CSPC Innovation's returns are expected to increase less than the market. However, during the bear market, the loss of holding CSPC Innovation is expected to be smaller as well. Please check CSPC Innovation's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether CSPC Innovation's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC Innovation Pharmaceutical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, CSPC Innovation sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0112 | Payout Ratio 1.2418 | Last Split Factor 1.2:1 | Forward Dividend Rate 0.32 | Ex Dividend Date 2024-04-25 |
1 | CSPC Pharma taps RD superstar in quest for new breakout drugs - Bamboo Works | 09/19/2024 |
2 | CSPC Innovation Reports Declining Financial Performance - TipRanks | 10/23/2024 |
| Begin Period Cash Flow | 2.2 B |
CSPC |
CSPC Innovation Relative Risk vs. Return Landscape
If you would invest 2,364 in CSPC Innovation Pharmaceutical on September 3, 2024 and sell it today you would earn a total of 487.00 from holding CSPC Innovation Pharmaceutical or generate 20.6% return on investment over 90 days. CSPC Innovation Pharmaceutical is generating 0.4237% of daily returns and assumes 4.5703% volatility on return distribution over the 90 days horizon. Simply put, 40% of stocks are less volatile than CSPC, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CSPC Innovation Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CSPC Innovation's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CSPC Innovation Pharmaceutical, and traders can use it to determine the average amount a CSPC Innovation's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0927
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300765 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.57 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average CSPC Innovation is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CSPC Innovation by adding it to a well-diversified portfolio.
CSPC Innovation Fundamentals Growth
CSPC Stock prices reflect investors' perceptions of the future prospects and financial health of CSPC Innovation, and CSPC Innovation fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CSPC Stock performance.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0603 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 38.75 B | |||
| Shares Outstanding | 1.4 B | |||
| Price To Book | 10.50 X | |||
| Price To Sales | 19.79 X | |||
| Revenue | 2.5 B | |||
| Gross Profit | 1.13 B | |||
| EBITDA | 654.85 M | |||
| Net Income | 755.56 M | |||
| Total Debt | 544.96 M | |||
| Book Value Per Share | 2.74 X | |||
| Cash Flow From Operations | 927.24 M | |||
| Earnings Per Share | 0.37 X | |||
| Total Asset | 5.63 B | |||
| Retained Earnings | 2.55 B | |||
About CSPC Innovation Performance
By analyzing CSPC Innovation's fundamental ratios, stakeholders can gain valuable insights into CSPC Innovation's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CSPC Innovation has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CSPC Innovation has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CSPC Innovation is entity of China. It is traded as Stock on SHE exchange.Things to note about CSPC Innovation Phar performance evaluation
Checking the ongoing alerts about CSPC Innovation for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CSPC Innovation Phar help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CSPC Innovation Phar had very high historical volatility over the last 90 days | |
| About 79.0% of the company shares are owned by insiders or employees |
- Analyzing CSPC Innovation's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CSPC Innovation's stock is overvalued or undervalued compared to its peers.
- Examining CSPC Innovation's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CSPC Innovation's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CSPC Innovation's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CSPC Innovation's stock. These opinions can provide insight into CSPC Innovation's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CSPC Stock analysis
When running CSPC Innovation's price analysis, check to measure CSPC Innovation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC Innovation is operating at the current time. Most of CSPC Innovation's value examination focuses on studying past and present price action to predict the probability of CSPC Innovation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC Innovation's price. Additionally, you may evaluate how the addition of CSPC Innovation to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |